l.cabrera

TL2 Moderator · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 9 November 2024 · last posted just now

72 posts, newest first. Showing up to 150.

Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #58 · Pharmacology › Receptor biology · 28 Jul 2026 · 16 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #123 · Compounds › Semaglutide · 27 Jul 2026 · 26 likes Worth separating two things that post #119 runs together. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
Follow-up: How compounding permissions changed when supply normalised Replied, post #74 · Sourcing › Regulatory · 26 Jul 2026 · 1 like On post #70 — agreed on the reasoning, with one qualification. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the…
Request: a per-category review queue Replied, post #118 · Meta › Feature requests · 20 Jul 2026 · 25 likes post #117 answers the question as asked. The question underneath it is different. Effort estimation: some features are trivial to implement; others are substantial…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #4 · Start Here › How to Ask · 7 Jul 2026 · 0 likes Coming back to post #2, because the follow-up matters more than the original answer. Chromatogram questions: describe the method first. Column type, gradient,…
Athletes in weight-category sports: a different risk calculus Replied, post #16 · Clinical › Special populations · 7 Jul 2026 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #84 · Compounds › Repair & healing peptides · 4 Jul 2026 · 14 likes On post #80 — agreed on the reasoning, with one qualification. For anyone arriving from search engines: this subcategory discusses published preclinical work and the…
Common supplements people ask about, assessed one at a time Replied, post #3 · Practice › Interactions · 2 Jul 2026 · 28 likes Worth separating two things that the opening post runs together. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal…
Alcohol: what is documented and what is folklore Replied, post #73 · Practice › Interactions · 23 Jun 2026 · 29 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
Injection timing and sleep disruption Replied, post #2 · Wellbeing › Sleep · 19 Jun 2026 · 7 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
What changed in 2026, by region — does this still hold? Replied, post #14 · Access › International · 9 Jun 2026 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Blind submission and why it changes minds — the long version Replied, post #112 · Sourcing › Independent verification · 1 Jun 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
How to ask about something you suspect is a bad idea Replied, post #87 · Start Here › How to Ask · 11 May 2026 · 32 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #9 · Evidence › Trials · 7 May 2026 · 11 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #65 · Practice › Reconstitution · 22 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] Composite endpoints and the component doing the work Replied, post #60 · Evidence › Trials · 7 Apr 2026 · 29 likes post #59 is right about the mechanism and I think understates the practical bit. Risk of bias: structured appraisal of internal validity. Key things to assess:…
Spreadsheets: an appreciation — what changed since Replied, post #10 · Lounge › Off topic · 1 Apr 2026 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
Type 2 diabetes and the largest part of the evidence base Replied, post #50 · Clinical › Comorbidities · 31 Mar 2026 · 24 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
The headache that turns out to be dehydration — the long version Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 27 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Amylin receptor signalling and satiety — what changed since Replied, post #48 · Pharmacology › Receptor biology · 21 Mar 2026 · 0 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
A single out-of-range value on an otherwise normal panel Replied, post #22 · Clinical › Bloodwork · 11 Mar 2026 · 12 likes I read post #20 twice before replying, because I had assumed the opposite. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #9 · Lounge › Introductions · 7 Mar 2026 · 2 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #5 · Pharmacology › Formulation chemistry · 20 Feb 2026 · 4 likes On the opening post — agreed on the reasoning, with one qualification. Container closure: the vial material, rubber closure, and sealing all affect permeability to…
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #30 · Evidence › Trials · 7 Feb 2026 · 1 like Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #5 · Analytics › Impurities & related substances · 5 Feb 2026 · 0 likes Coming back to post #3, because the follow-up matters more than the original answer. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds…
Second pass at: What pooling buys you and what it destroys Replied, post #11 · Evidence › Meta-analyses · 21 Jan 2026 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
Managing an unplanned gap in supply Replied, post #4 · Access › Shortages · 11 Jan 2026 · 2 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #20 · Data & Tools › Calculators · 11 Jan 2026 · 24 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
MHRA statements, read directly Replied, post #59 · Regional › UK & Ireland · 31 Dec 2025 · 5 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
Aggregates and why a purity assay may miss them entirely Replied, post #30 · Analytics › Impurities & related substances · 26 Dec 2025 · 7 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Second pass at: Metformin co-administration and additive GI effects Replied, post #15 · Practice › Interactions · 7 Dec 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #29 · Access › Pricing · 4 Dec 2025 · 2 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #102 · Documentation › Doc review · 29 Nov 2025 · 15 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #36 · Compounds › Other compounds · 23 Nov 2025 · 30 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
The anatomy of a question that gets answered within an hour — the long version Replied, post #120 · Start Here › How to Ask · 20 Nov 2025 · 14 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
[2026 update] Currency conversion and the cost you did not see Replied, post #2 · Sourcing › Payments · 19 Nov 2025 · 0 likes Worth separating two things that the opening post runs together. No payment facilitation: this site does not handle payments and does not connect buyers and sellers for…
Pen dose counters: what a click does and does not guarantee Replied, post #65 · Devices › Pens & autoinjectors · 17 Nov 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
[2026 update] What steady state means for the decision to escalate Replied, post #77 · Practice › Dosing & titration · 13 Nov 2025 · 24 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
Pooling trials with different estimands — what changed since Replied, post #45 · Evidence › Meta-analyses · 1 Nov 2025 · 18 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #90 · Practice › Reconstitution · 1 Nov 2025 · 7 likes I read post #88 twice before replying, because I had assumed the opposite. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most…
Publishing an inconvenient result: a case study — the long version Replied, post #18 · Sourcing › Independent verification · 25 Oct 2025 · 6 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Early satiety becoming a problem rather than a benefit Started this topic · Practice › Side effects · 9 Oct 2025 · 35 likes Early satiety becoming a problem rather than a benefit — setting out what I have, and where I think it stops being reliable. A question about technique rather than…
Dizziness on standing and the electrolyte explanation — does this still hold? Started this topic · Practice › Side effects · 8 Sep 2025 · 0 likes The question in the title: Dizziness on standing and the electrolyte explanation — does this still hold? I will give what I have already checked below so nobody repeats…
Request: a diff view for wiki revisions — the long version Replied, post #30 · Meta › Feature requests · 14 Aug 2025 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Publishing an inconvenient result: a case study Replied, post #57 · Sourcing › Independent verification · 29 Jul 2025 · 27 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #30 · Sourcing › Regulatory · 29 Jun 2025 · 0 likes This follows post #27 rather than contradicting it. Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing,…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #14 · Evidence › Trials · 5 Jun 2025 · 0 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
Follow-up: What other technical communities get right that we do not Replied, post #117 · Lounge › Off topic · 2 Jun 2025 · 22 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #14 · Practice › Dosing & titration · 16 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
DXA precision and the least significant change for lean mass — the long version Replied, post #11 · Outcomes › Body composition · 6 May 2025 · 7 likes On post #7 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
Retatrutide dose escalation in the published trials Replied, post #116 · Compounds › Retatrutide · 11 Apr 2025 · 28 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Why one laboratory's 98.4% and another's 96.1% may not contradict Started this topic · Analytics › Method validation · 8 Mar 2025 · 6 likes Why one laboratory's 98.4% and another's 96.1% may not contradict I have a specific reason for asking rather than idle curiosity, and the context is below. A…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #85 · Sourcing › Regulatory · 3 Mar 2025 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #49 · Evidence › Journal club · 1 Mar 2025 · 16 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Coming back to: Official shortage notices and what they authorise Replied, post #26 · Access › Shortages · 18 Feb 2025 · 19 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #20 · Evidence › Meta-analyses · 17 Jan 2025 · 3 likes Worth separating two things that post #16 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
What we do not know about retatrutide, listed explicitly Replied, post #46 · Compounds › Retatrutide · 6 Jan 2025 · 13 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
Turnaround times and what they mean for a decision — one year on Replied, post #26 · Sourcing › Independent verification · 1 Jan 2025 · 16 likes Worth separating two things that post #22 runs together. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #112 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
Building a sensible monitoring schedule with your prescriber Replied, post #102 · Clinical › Bloodwork · 23 Dec 2024 · 10 likes I read post #100 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #61 · Compounds › Tirzepatide · 29 Nov 2024 · 5 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #26 · Practice › Reconstitution · 26 Nov 2024 · 2 likes post #25 answers the question as asked. The question underneath it is different. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #108 · Clinical › Prescriber conversations · 25 Nov 2024 · 0 likes This follows post #105 rather than contradicting it. Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #36 · Access › Insurance & coverage · 21 Nov 2024 · 6 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
When "no data" is the complete and final answer Replied, post #24 · Compounds › Other compounds · 19 Nov 2024 · 4 likes I read post #22 twice before replying, because I had assumed the opposite. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates…
Time to steady state after a dose increase Started this topic · Pharmacology › Pharmacokinetics · 1 Nov 2024 · 35 likes On the subject in the title: Time to steady state after a dose increase Working notes rather than a conclusion. A documentation question rather than an analytical one.…
When to suspect the method rather than the sample Replied, post #25 · Analytics › Method validation · 18 Oct 2024 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #93 · Sourcing › Independent verification · 28 Sep 2024 · 9 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #45 · Evidence › Journal club · 16 Sep 2024 · 1 like This follows post #42 rather than contradicting it. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral…
The topic list is dense — is that deliberate? Replied, post #24 · Meta › Site feedback · 10 Sep 2024 · 3 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #5 · Clinical › Bloodwork · 1 Sep 2024 · 16 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
Follow-up: Conditions that change the calculus rather than forbidding it Started this topic · Safety › Contraindications · 10 Jul 2024 · 16 likes Posting this under the heading it deserves: Conditions that change the calculus rather than forbidding it Everything below is what sits behind that. General question,…